International Sanctions Medicine .

1. International Sanctions and Medicines: Legal Framework

(A) What are sanctions in this context?

International sanctions are restrictive measures imposed by:

  • United Nations Security Council (UNSC)
  • United States (OFAC – Office of Foreign Assets Control)
  • European Union (EU restrictive measures)
  • Regional blocs or individual states

They may include:

  • Trade embargoes
  • Asset freezes
  • Banking restrictions (SWIFT restrictions, payment blocking)
  • Export controls (including medical equipment or pharma inputs)

(B) Medicines and “Humanitarian Exemption”

Most modern sanctions laws include exemptions for:

  • Medicines and medical devices
  • Food and humanitarian supplies

However, problems arise due to:

  • Bank de-risking (banks refuse to process any related payments)
  • Dual-use classification issues (some biotech items restricted)
  • Licensing delays
  • Fear of penalties (“over-compliance”)

2. Key Case Laws and Landmark Situations

Case 1: Iraq – UN Sanctions & Oil-for-Food Programme (1990–2003)

Background

After Iraq’s invasion of Kuwait, UNSC Resolution 661 imposed comprehensive sanctions.

To reduce humanitarian harm, the UN created the Oil-for-Food Programme (UNSC Resolution 986) allowing Iraq to sell oil in exchange for food and medicines.

Legal Issue

Although medicines were technically allowed, the system required:

  • UN approval of contracts
  • Monitoring of distribution
  • Payment through controlled escrow accounts

Impact on Medicines

  • Chronic shortages of essential drugs (antibiotics, cancer treatment drugs)
  • Hospitals lacked basic supplies due to delayed approvals
  • Infrastructure deterioration worsened healthcare collapse

Legal Significance

This became a benchmark case for “humanitarian impact of comprehensive sanctions”, leading to modern preference for targeted sanctions instead of blanket embargoes.

Case 2: Iran Sanctions & Banking Overcompliance (2006–present)

Background

The US, EU, and UN imposed layered sanctions over Iran’s nuclear program.

Medicines were exempt under law, but financial channels were heavily restricted.

Legal Issue

Even when pharmaceutical goods were legal, payments could not be processed due to:

  • Iranian banks being cut off from SWIFT (2012 EU sanctions escalation)
  • US secondary sanctions threatening foreign banks

Case Example: Banking Restrictions Effect on Medicine Imports

Hospitals in Iran reported inability to pay foreign suppliers for:

  • Hemophilia medication
  • Cancer chemotherapy drugs
  • Immunosuppressants for transplant patients

Legal Significance

This situation illustrates the doctrine of:

“De facto humanitarian blockade through financial restrictions”

It has been widely discussed in UN Human Rights reports as indirect violation of the right to health.

Case 3: BNP Paribas Sanctions Enforcement Case (2014, US)

Background

BNP Paribas was fined by US authorities for violating sanctions against Sudan, Iran, and Cuba.

Legal Issue

The bank:

  • Processed billions of dollars in prohibited transactions
  • Removed identifying information to hide sanctioned-country involvement
  • Used US financial system despite restrictions

Outcome

  • Record fine (~$8.9 billion)
  • Temporary restrictions on USD clearing operations

Link to Medicines

Although not a pharma company case, it had a direct impact because:

  • Banks globally became extremely risk-averse
  • Pharmaceutical trade financing for sanctioned countries became harder
  • Even legal humanitarian transactions were delayed or rejected

Legal Significance

Established strict liability for sanctions violations and triggered global over-compliance in humanitarian sectors.

Case 4: Kadi v. Council of the EU (EU Court of Justice, 2008 & 2013)

Background

Yassin Abdullah Kadi challenged EU sanctions imposed due to alleged links with terrorism under UN listing.

Legal Issue

Kadi argued:

  • His asset freeze violated fundamental rights
  • No fair hearing or judicial review was provided

Court Findings

The European Court ruled:

  • EU must respect fundamental rights even when implementing UN sanctions
  • Individuals must have right to challenge listing

Impact on Medicines Context

Although not directly about medicine, it affected:

  • Humanitarian financing restrictions
  • NGO ability to fund medical shipments
  • Due process in sanctions affecting healthcare-related trade

Legal Significance

Created the principle:

“Sanctions must comply with constitutional and human rights standards even when implementing UN mandates.”

Case 5: Sudan Sanctions & Humanitarian Medicine Access (1997–2017)

Background

The US imposed comprehensive sanctions on Sudan under Executive Orders targeting:

  • Government entities
  • Oil sector
  • Financial system

Medicines were formally exempt.

Legal Issue

Despite exemptions:

  • Banks refused to finance medical imports
  • Pharmaceutical companies avoided Sudan due to compliance risk
  • NGOs faced licensing delays from OFAC

Real-World Impact

  • Shortages of malaria and tuberculosis treatments
  • Difficulty importing insulin and dialysis equipment
  • Rural healthcare collapse

Legal Significance

Led to recognition of the concept:

“Humanitarian exemption gap” — legal permission exists but practical access is blocked.

Sanctions were eventually eased in 2017 partly due to humanitarian concerns.

Case 6: North Korea Sanctions & Humanitarian Licensing System

Background

UN sanctions on North Korea allow medical goods but require monitoring and approvals.

Legal Issue

Humanitarian organizations must:

  • Apply for sanctions exemptions
  • Submit detailed shipment tracking
  • Undergo inspection requirements

Impact on Medicine Supply

  • Delays in vaccines and tuberculosis medication
  • NGOs reducing operations due to administrative burden
  • Difficulty importing medical imaging equipment due to dual-use concerns

Legal Significance

Shows how even targeted sanctions regimes can indirectly restrict healthcare delivery due to compliance complexity.

3. Key Legal Principles Derived from These Cases

Across all cases, international jurisprudence and practice show:

(1) De jure vs De facto Access Gap

Even when medicines are legally exempt, access may be blocked in practice.

(2) Financial Sanctions Are the Real Bottleneck

Banking restrictions often matter more than trade bans.

(3) Over-Compliance Effect

Private companies and banks often avoid legal trade due to fear of penalties.

(4) Human Rights Constraints Are Increasingly Relevant

Courts (especially in Europe) recognize:

  • Right to health
  • Due process in sanctions listing

(5) Shift from Comprehensive to Targeted Sanctions

Due to humanitarian crises in Iraq and Sudan, modern sanctions prefer:

  • Individual asset freezes
  • Sector-specific restrictions

4. Conclusion

International sanctions rarely prohibit medicines directly, but the legal architecture around them—especially financial restrictions and compliance risk—can significantly restrict access to essential healthcare.

The cases of Iraq (Oil-for-Food), Iran, BNP Paribas enforcement effects, Kadi litigation, Sudan sanctions, and North Korea humanitarian restrictions collectively show a consistent legal pattern:

Modern sanctions law must balance security objectives with the non-derogable right to health.

LEAVE A COMMENT